Company profile for Adamis Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2006 and headquartered in San Diego, Adamis (ADMP) is a specialty biopharmaceutical company that provides high quality, lower-cost solutions for patients, physicians, and healthcare organizations in the multi-billion dollar therapeutic areas of respiratory disease and allergies. The Company’s first approved product, SYMJEPI (epinephrine) Injection is an epinephrine injection pre-filled syringe product for use in t...
Founded in 2006 and headquartered in San Diego, Adamis (ADMP) is a specialty biopharmaceutical company that provides high quality, lower-cost solutions for patients, physicians, and healthcare organizations in the multi-billion dollar therapeutic areas of respiratory disease and allergies. The Company’s first approved product, SYMJEPI (epinephrine) Injection is an epinephrine injection pre-filled syringe product for use in the emergency treatment of anaphylaxis. Adamis is also currently developing other specialty pharmaceutical product candidates including APC-1000, an HFA inhaled nasal steroid product for the potential treatment of asthma.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11682 El Camino Real, Suite # 300 San Diego, CA 92130
Telephone
Telephone
858-997-2400
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2023/09/07/2739656/32832/en/Adamis-Pharmaceuticals-Changes-Name-to-DMK-Pharmaceuticals-to-Reflect-New-Strategic-Focus.html

GLOBENEWSWIRE
07 Sep 2023

https://www.contractpharma.com/contents/view_breaking-news/2023-09-07/adamis-pharmaceuticals-changes-name-to-dmk-pharmac/?widget=listSection

CONTRACT PHARMA
07 Sep 2023

https://www.globenewswire.com//news-release/2023/08/21/2728733/32832/en/Adamis-Pharmaceuticals-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
21 Aug 2023

https://www.globenewswire.com/news-release/2023/08/04/2719209/32832/en/Adamis-Pharmaceuticals-Announces-Closing-of-8-0-Million-Public-Offering.html

GLOBENEWSWIRE
04 Aug 2023

https://www.globenewswire.com/news-release/2023/08/02/2716855/32832/en/Adamis-Pharmaceuticals-Announces-Pricing-of-8-0-Million-Public-Offering.html

GLOBENEWSWIRE
02 Aug 2023

https://www.globenewswire.com/news-release/2023/07/28/2713122/32832/en/Adamis-Pharmaceuticals-to-Fund-ZIMHI-Clinical-Study-with-University-of-Leiden-Opioid-Expert.html

GLOBENEWSWIRE
28 Jul 2023

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty